top of page

TBCRE Investigator / TB related publications 2023

Still being updated...

 

2023


1.    Rapid and accurate diagnosis of paediatric tuberculosis through combination of a novel GeneXpert Host Gene Transcription Assay and Xpert®MTB/RIF Ultra. Olbrich L, Valsan P, Verghese VP, Franckling-Smith Z, Sabi I, Ntinginya EN, Mfinanga A, Banze D, Viegas, Khosa C, Semphere R, Nliwasa M, McHugh TD, Larsson L, Razid A, Song R, Corbett EL, Nabeta P, Trollip A, Graham SM, Hoelscher M, Geldmacher C, Zar HJ, Michael JS, Heinrich N. Lancet Infect Dis 2023 (in press)
2.    Effectiveness of a community-based approach for tuberculosis household child contact investigation and management: a cluster randomized trial in Cameroon and Uganda. Bonnet M, Vasiliu A, Tchounga BK, Cuer B, Fielding K, Ssekyanzi B, Tchakounte BY, Cohn J, Dodd PJ, Tiendrebeogo G, Tchengou P, Simo L, Okello R, Kuate A, Turyahabwe S, Atwine D, Graham SM, Casenghi M, CONTACT study group. Lancet Glob Health 2023 (in press)
3.    Pre-XDR congenital tuberculosis in an extremely premature baby. Boast A, How JA, Lau C, Sett, A. Gilby D, Burke A, McWhinney B, Wright C, Tramontana A, Globan M, Denholm J, Graham SM, Osowicki J. Clin Infect Dis 2023
4.    The clinical presentation and detection of tuberculosis during pregnancy and in the postpartum period in low- and middle-income countries: a systematic review and meta-analysis. Simpson G, Philip M, Vogel JP, Scoullar M, Graham SM, Wilson AN. PLoS Glob Public Health 2023; 3: e00022
5.    Prevalence, clinical presentation and factors associated with chronic lung disease among children and adolescents living with HIV in Kenya. Obimbo EM, Attia E, Were FN, Jacko W, Graham SM. PLoS ONE 2023; 18: e0289756
6.    Clinical standards for drug-susceptible tuberculosis in children and adolescents. Chiang SS, Graham SM, Schaaf HS, Marais BJ, Sant’Anna CC, Sharma S, et al. Int J Tuberc Lung Dis 2023; 27: 584-598
7.    The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study from 1990 to 2019. Azzopardi PS, Kerr JA, Sawyer SM, Kennedy EC, Steer AC, Graham SM, et al. GBD 2019 Adolescent Communicable Disease Collaboration. Lancet 2023
8.    Clinical standards for drug-susceptible tuberculosis in children and adolescents. Chiang SS, Graham SM, Schaaf HS, Marais BJ, Sant’Anna CC, Sharma S, Starke JR, Triasih R, et al. Int J Tuberc Lung Dis 2023
9.    Development and validation of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. Gunasekera K, Marcy O, Munoz J, Lopez-Varela E, Sekadde MP, Franke M, et al. Lancet Child Adol Health 2023; 7: 336-346
10.    Beyond patient delay, navigating structural health system barriers to timely care and treatment in a high burden TB setting in Papua New Guinea. Jops P, Cowan J, Kupul M, Trumb RN, Graham SM, Bauri M, et al. Glob Public Health 2023; 18: 2184482
11.    Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis. Gafar F, Wasmann R, McIlleron H, Aarnoutse R, Schaaf HS, Marais B, et al. Eur Resp J 2023; 61: 2201596
12.    Rapid and accurate diagnosis of pediatric tuberculosis disease (RaPaed-TB): A diagnostic accuracy study for pediatric tuberculosis. Olbrich L, Nliwasa M, Sabi I, Ntinginya N, Khosa C, Banze D, Corbett EL, Semphere R, Verghese VP, Sarojini Michael J, Graham SM, et al; on behalf of the RaPaed-AIDA-TB Consortium. Pediatr Infect Dis J 2023: 42; 353-360
13.    Impact of systematic tuberculosis detection on mortality in young children with severe pneumonia in high tuberculosis incidence countries – a stepped wedge cluster randomized trial. Marcy O, Wobudeya E, Font H, Vessiere A, Chabala C, Khosa C, Taguebue JV, Moh R, Mwanga-Amumpaire J, Lounnas M, Mulenga V, Mavale S, Chilundo J, Rego D, Nduna B, Shankalala P, Chirwa U, De Lauzanne A, Dim B, Tiogouo Ngouana E, Folquet Amorrissani M, Cisse L, Amon Tanoh Dick F, Komena EA, Kwedi Nolna S, Businge G, Natukunda N, Cumbe S, Mbekeka P, Kim A, Kheang C, Pol S, Maleche-Obimbo E, Seddon JA, Mao TE, Graham SM, Delacourt C, Borand L, Bonnet M; TB-Speed Pneumonia Study group. Lancet Infect Dis 2023; 38: 341-351
14.    Towards shorter, child-friendly regimens for treatment of tuberculosis disease and infection in children. Yuen CM, Sekadde MP, Kaiser B, Waning B, Graham SM. Pediatr Infect Dis J 2023; 42: e77-e79
15.    Contact screening and management in a high-transmission MDR-TB setting in Papua New Guinea: progress, challenges and future directions. Majumdar SS, Islam S, Huang GKL, Morris L, Bauri M, Chan G, Kama G, Keam T, Peacock-Smith A, Finch S, Marukutira T, Bhatt S, Drewett G, Wratten M, Murray A, Pank N, Masah C, Bala R, Umali S, Kalon S, Greig J, Chani K, Kal M, Graham SM. Frontiers Trop Dis 2023; 3
16.    A scoping review of lung function in children and adolescents living with HIV in the era of antiretroviral treatment. Liu J, Maleche-Obimbo E, Shanthikumar S, Graham SM. Pediatr Pulmonol 2023; 58: 1344-1354
17.    Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis. Obimbo Maleche E, Atieno Odhiambo M, Njeri L, Mburu M, Jaoko W, Were F, Graham SM. PLoS Glob Public Health 2022; 2: e0000805
18.    Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014-2021. Lestari T, Kamaludin, Lowbridge C, Kenangalem E, Poespoprodjo JR, Graham SM, Ralph AP. PLoS Glob Pub Health 2022; 2: e0001114 
19.    Tuberculous meningitis in children: a forgotten public health emergency. Du Preez K, Jenkins HE, Donald PR, Solomons RS, Graham SM, Schaaf HS, Starke JR, Hesseling AC, Seddon JA. Front Neurol 2022; 13: 751133
20.    A systematic review of clinical, epidemiological and demographic predictors of tuberculosis in children with pneumonia. Kazi S, Corcoran H, Abo YN, Graham H, Oliwa J, Graham SM; ARI review group. J Glob Health 2022; 12: 10010
21.    Management of tuberculosis infection in Victorian children: A retrospective clinical audit of factors affecting treatment completion. Holmes RH, Sun S, Kazi S, Ranganathan S, Tosif S, Graham SM, Graham H. PLoS ONE 2022: 17: e0275789
22.    Detecting Mycobacterium tuberculosis infection in children migrating to Australia. Laemmle-Ruff I, Graham SM, Williams B, Horyniak D, Majumdar SS, Paxton GA, Soares Caplice LV, Hellard ME, Trauer JM. Emerg Infect Dis 2022; 28: 1833-1841
23.    Exploring tuberculosis riskscapes in a Papua New Guinea hotspot. Jops P, Kupul M, Trumb RN, Cowan J, Graham SM, Bell S, Majumdar S, Nindil H, Pomat W, Marais B, Marks G, Vallely AJ, Kaldor J, Kelly-Hanku A. Qual Health Res 2022 
24.    Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Martinez L, Cords O, Acuna-Villaorduna C, et al. Lancet Glob Health 2022; 10: e1307-e1316
25.    Performance of Xpert MTB/RIF and mycobacterial culture on multiple specimen types for diagnosis of tuberculosis disease in young children and clinical characterization according to standardized research case definitions. Click E, Song R, Andres M, Smith JP, Mchembere W, Fajans M, Hariri P, Fajans M, Hariri P, Okeyo E, McCarthy KD, Gethi D, Odeny L, Musau S, Okumu A, Orwa J, Perez-Velez CM, Wright CA, Andres M, Marais BJ, Schaaf HS, Graham SM, Cruz AT, Cain KP. Pediatr Infect Dis J 2022; 41: 671-677
26.    Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea. Bainomugisa A, Lavu E, Pandey S, Majumdar S, Banamu J, Coulter C, Marais B, Coin L, Graham SM, du Cros P. BMC Infect Dis 2022; 22: 437
27.    Tuberculosis infection in children and adolescents. Youngui BT, Tchounga BT, Graham SM, Bonnet M. Pathogens 2022; 11: 1512
28.    Diagnostic challenges in childhood pulmonary tuberculosis – optimizing the clinical approach. Gunasekera KS, Vonasek B, Oliwa J, Triasih R, Lancioni C, Graham SM, Seddon JA, Marais BJ. Pathogens 2022; 11: 382
29.    Shorter treatment for non-severe tuberculosis in African and Indian children. Turkova A, Wills GH, Wobudeya E, Chabala C, Palmer M, Kinikar A, Hissar S, Choo L, Musoke P, Mulenga V, Mave V, Joseph B, LeBeau K, Thomason MJ, Muboizi RB, Kapasa M, van der Zalm M, Raichur P, Bhavani PK, McIlleron H, Demers A-M, Aarnouste R, Love-Koh J, Seddon JA, Welch SB, Graham SM, Hesseling A, Gibb DM, Crook AM, and the SHINE Trial Team. N Engl J Med 2022; 386: 911-922
30.    Clinical standards for the diagnosis, treatment and prevention of TB infection. Migliori GB, Wu SJ, Matteelli A, Zenner D, Goletti D, Ahmedov S, Al-Abri S, Allen DM, Balcells ME, Garcia Basteiro AL, Cambau E, Chaisson RE, Chee CBE, Dalcolmo MP, Denholm JT, Erkens C, Esposito S, Farnia P, Friedland JS, Graham S, et al. Int J Tuberc Lung Dis 2022; 26: 190-205
31.    Priority activities in child and adolescent tuberculosis to close the policy-practice gap in low- and middle-income countries. du Preez K, Gabardo BMA, Kabra SK, Triasih R, Lestari T, Kal M, Tsogt B, Dorj G, Purev E, Nguyen TA, Naidoo L, Mvusi L, Schaaf HS, Hesseling AC, de Oliveira Rossoni AM, Carvalho ACC, Cardoso CAA, Sant'Anna CC, Orti DGD, Costa FD, Vega LR, Sant'Anna MFP, Hoa NB, Phuc PH, Fiogbe AA, Affolabi D, Badoum G, Ouédraogo AR, Saouadogo T, Combary A, Kuate Kuate A, Prudence BNA, Magassouba AS, Bangoura AM, Soumana A, Hermana G, Gando H, Fall N, Gning B, Dogo MF, Mbitikon O, Deffense M, Zimba K, Chabala C, Sekadde MP, Luzze H, Turyahabwe S, Dongo JP, Lopes C, Dos Santos M, Francis JR, Arango-Loboguerrero M, Perez-Velez CM, Koura KG, Graham SM. Pathogens 2022; 11: 196

Wave

WHO rapid communication on updated guidance for the management of TB in children and adolescents

who-logo-world-health-organization-logo.png

Our TB-CRE Chief Investigator Prof Steve Graham contributed to drafting the recent important updates to WHO guidance on the management of tuberculosis (TB) in children and adolescents. The updates include new recommendations on diagnostic options, treatment regimens, treatment decision algorithms, and optimal models of care for the delivery of child and adolescent TB services.

link to publication>

2020 / 2021 Publications by theme:

Developing efficient active TB case finding strategies, new models of care to reduce TB mortality and improve outcomes, TB importation into Australia

Household contact/community screening and treatment of LTBI, and developing optimal approaches for LTBI management in Australia

Drug resistance surveillance, clinical trials, personalised treatment of TB and the role of Whole Genome Sequencing (WGS), Pharmacokinetics, and vaccine development

Child and adolescent TB, co-morbidities

Theme 1: FInd and treat 

Find and Treat Papers

Theme 2: Prevent 

Theme 2 Prevent

Theme 3: Emerging Drug-Resistant TB

Theme 3: Emerging Drug-Resistant TB

Theme 4: Vulnerable Populations

Theme 4: Vulnerable Populations

2020 Publications (early)

TB-CRE Investigator TB-related publications

Pittet LF, Tebruegge M, Dutta B, Donath S, Messina N, Casalaz D, Hanekom WA, Britton WJ, Robins-Browne R, Curtis N and Ritz N (2020). "Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine." Vaccine 39(4): 652-657.

 

Velen K, Nhung NV, Anh NT, Cuong PD, Hoa NB, Cuong NK, Dung NH, Sy DN, Britton WJ, Marks GB, Fox GJ (2020). "Risk Factors for Tuberculosis (TB) Among Household Contacts of Patients With Smear-Positive TB in 8 Provinces of Vietnam: A Nested Case-Control Study". Clinical Infectious Diseases.

Counoupas C, Ferrell KC, Ashhurst A, Bhattacharyya ND, Nagalingam G, Stewart EL, Feng CG, Petrovsky N, Britton WJ, Triccas JA. (2020) "Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis". npj Vaccines; 5: 105.

Ho J, Bokil NJ, Nguyen PTB, Nguyen TA, Liu MY, Hare N, Fox GJ, Saunders BM, Marks GB, Britton WJ (2020). "A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort". Journal of Infection; 81: 72-80.

Nguyen B., Fox G.J., Mason P.H., Denholm J.T. (2020) "Preventive Therapy for Multidrug Resistant Latent Tuberculosis Infection: An Ethical Imperative with Ethical Barriers to Implementation?". In: Jamrozik E., Selgelid M. (eds) Ethics and Drug Resistance: Collective Responsibility for Global Public Health. Public Health Ethics Analysis, vol 5. Springer, Cham.

A. Bainomugisa, C. Gilpin, C. Coulter, and B. J. Maris (2020) "New Xpert MTB/XDR: added value and future in the field." Eur Respir J 2020; 56: 2003616.

Bhattacharyya ND, Counoupas C, Daniel L, Zhang G, Cook SJ, Cootes TA, Stifter SA, Bowen DG, Triccas JA, Bertolino P, Britton WJ, Feng CG (2020). "TCR affinity controls the dynamics but not the functional specification of the Th1 response to mycobacteria". bioRxiv: 2020.2010.2025.353763.

Quan DH, Counoupas C, Nagalingam G, Pinto R, Petrovsky N, Britton WJ, Triccas JA (2020). "Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity". bioRxiv: 2020.2010.2001.323105.

Bachmann, N. L., R. Salamzade, A. L. Manson, R. Whittington, V. Sintchenko, A. M. Earl and B. J. Marais (2019). "Key Transitions in the Evolution of Rapid and Slow Growing Mycobacteria Identified by Comparative Genomics." Front Microbiol 10: 3019.


Abidi, S., J. Achar, M. M. Assao Neino, D. Bang, A. Benedetti, S. Brode, J. R. Campbell, E. C. Casas, F. Conradie, G. Dravniece, P. du Cros, D. Falzon, E. Jaramillo, C. Kuaban, Z. Lan, C. Lange, P. Z. Li, M. Makhmudova, A. K. J. Maug, D. Menzies, G. B. Migliori, A. Miller, B. Myrzaliev, N. Ndjeka, J. Noeske, N. Parpieva, A. Piubello, V. Schwoebel, W. Sikhondze, R. Singla, M. B. Souleymane, A. Trébucq, A. Van Deun, K. Viney, K. Weyer, B. J. Zhang and F. Ahmad Khan (2020). "Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis." Eur Respir J 55(3).


Al Abri, S., T. Kasaeva, G. B. Migliori, D. Goletti, D. Zenner, J. Denholm, A. Al Maani, D. M. Cirillo, T. Schön, T. Lillebæk, A. Al-Jardani, U. Y. Go, H. M. Dias, S. Tiberi, F. Al Yaquobi, F. A. Khamis, P. Kurup, M. Wilson, Z. Memish, A. Al Maqbali, M. Akhtar, C. Wejse and E. Petersen (2020). "Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries." Int J Infect Dis 92s: S60-s68.


Alene, K. A., K. Viney, D. J. Gray, E. S. McBryde, Z. Xu and A. C. A. Clements (2020). "Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis." PLoS One 15(1): e0227100.


Biermann, O., S. Atkins, K. Lönnroth, M. Caws and K. Viney (2020). "'Power plays plus push': experts' insights into the development and implementation of active tuberculosis case-finding policies globally, a qualitative study." BMJ Open 10(6): e036285.


Chakaya, J. M., A. D. Harries and G. B. Marks (2020). "Ending tuberculosis by 2030-Pipe dream or reality?" Int J Infect Dis 92s: S51-s54.


Chakaya, J. M., B. Marais, P. du Cros, F. Ntoumi, S. Mfinanga, N. Kapata, S. E. Hasnain, R. Nathavitharana and A. Zumla (2020). "Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis." Lancet Respir Med 8(4): 334-335.


Dale, K. D., J. M. Trauer, P. J. Dodd, R. Houben and J. T. Denholm (2020). "Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants." Clin Infect Dis 70(10): 2111-2118.


Degeling, C., J. Carroll, J. Denholm, B. Marais and A. Dawson (2020). "Ending TB in Australia: Organizational challenges for regional tuberculosis programs." Health Policy 124(1): 106-112.


Denholm, J., A. M. Baker and M. Timlin (2020). "Latent tuberculosis in the general practice context." Aust J Gen Pract 49(3): 107-110.


Fox, G. J., C. B. Nguyen, T. A. Nguyen, P. T. Tran, B. J. Marais, S. M. Graham, B. H. Nguyen, K. Velen, D. W. Dowdy, P. Mason, W. J. Britton, M. A. Behr, A. Benedetti, D. Menzies, V. N. Nguyen and G. B. Marks (2020). "Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial." BMJ Open 10(1): e033945.


Fox, G. J., L. Redwood, V. Chang and J. Ho (2020). "The effectiveness of individual and environmental infection control measures in reducing the transmission of Mycobacterium tuberculosis: a systematic review." Clin Infect Dis.


Ganmaa, D., B. Uyanga, X. Zhou, G. Gantsetseg, B. Delgerekh, D. Enkhmaa, D. Khulan, S. Ariunzaya, E. Sumiya, B. Bolortuya, J. Yanjmaa, T. Enkhtsetseg, A. Munkhzaya, M. Tunsag, P. Khudyakov, J. A. Seddon, B. J. Marais, O. Batbayar, G. Erdenetuya, B. Amarsaikhan, D. Spiegelman, J. Tsolmon and A. R. Martineau (2020). "Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease." N Engl J Med 383(4): 359-368.


Goroh, M. M. D., G. S. Rajahram, R. Avoi, C. H. A. Van Den Boogaard, T. William, A. P. Ralph and C. Lowbridge (2020). "Epidemiology of tuberculosis in Sabah, Malaysia, 2012-2018." Infect Dis Poverty 9(1): 119.


Goroh, M. M. D., C. H. A. van den Boogaard, M. Y. Ibrahim, N. O. Tha, Swe, F. Robinson, K. A. Lukman, M. S. Jeffree, T. William and A. P. Ralph (2020). "Factors Affecting Continued Participation in Tuberculosis Contact Investigation in a Low-Income, High-Burden Setting." Trop Med Infect Dis 5(3).


Gröschel, M. I., J. A. Seddon, S. A. Prabowo, G. B. Migliori, S. M. Graham, M. van den Boom and M. Dara (2020). "European guidance on drug-resistant tuberculosis in children and adolescents." Lancet Child Adolesc Health 4(1): 9-11.


Hawkins, P., W. Tran, G. Nagalingam, C. Y. Cheung, A. Giltrap, G. Cook, W. Britton and R. J. Payne (2020). "Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and Ecumicin." Chemistry.


Ho, J., N. J. Bokil, P. T. B. Nguyen, T. A. Nguyen, M. Y. Liu, N. Hare, G. J. Fox, B. M. Saunders, G. B. Marks and W. J. Britton (2020). "A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort." J Infect 81(1): 72-80.


Howard-Jones, A. R. and B. J. Marais (2020). "Tuberculosis in children: screening, diagnosis and management." Curr Opin Pediatr 32(3): 395-404.


Huynh, J., G. Thwaites, B. J. Marais and H. S. Schaaf (2020). "Tuberculosis treatment in children: The changing landscape." Paediatr Respir Rev.


K.J, S., B. A, H. G.K and G. S.M (2020). "Tuberculosis in pregnant women and neonates: A meta-review of current evidence." Paediatric Respiratory Reviews.


Karmakar, M., C. H. M. Rodrigues, K. Horan, J. T. Denholm and D. B. Ascher (2020). "Structure guided prediction of Pyrazinamide resistance mutations in pncA." Sci Rep 10(1): 1875.


Kim, H. Y., S. K. Heysell, S. Mpagama, B. J. Marais and J. W. Alffenaar (2020). "Challenging the management of drug-resistant tuberculosis." Lancet 395(10226): 783.


Kim, H. Y., S. Srivastava, H. K. Ak, B. J. Marais and J. W. Alffenaar (2020). "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment." Antimicrob Agents Chemother 64(7).


Kim, H. Y., S. Srivastava, H. Kumar Ak, B. J. Marais and J. W. Alffenaar (2020). "Optimal dose or optimal exposure? Consideration for linezolid in tuberculosis treatment." Antimicrob Agents Chemother.


Kuddus, M. A., M. T. Meehan, L. J. White, E. S. McBryde and A. I. Adekunle (2020). "Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh." PLoS One 15(7): e0236112.


Lisboa, M., I. Fronteira, P. H. Mason and M. Martins (2020). "National TB program shortages as potential factor for poor-quality TB care cascade: Healthcare workers' perspective from Beira, Mozambique." PLoS One 15(2): e0228927.


Lisboa, M., I. Fronteira, P. H. Mason and M. Martins (2020). "Using hospital auxiliary worker and 24-h TB services as potential tools to overcome in-hospital TB delays: a quasi-experimental study." Hum Resour Health 18(1): 28.


Lowbridge, C., S. A. M. Fadhil, G. D. Krishnan, E. Schimann, R. M. Karuppan, N. Sriram, G. S. Rajahram, J. Menon, A. Patel, T. William, D. C. Paul and A. P. Ralph (2020). "How can gastro-intestinal tuberculosis diagnosis be improved? A prospective cohort study." BMC Infect Dis 20(1): 255.


Majumdar, S. S., R. Triasih and S. M. Graham (2020). "Scaling up tuberculosis preventive therapy for contacts in high transmission settings." Lancet Glob Health 8(5): e617-e618.


Marais, B. J. (2020). "Improved urine LAM tests - the answer for child TB diagnosis?" Clin Infect Dis.


Marais, B. J. (2020). "Good outcomes in babies with in-utero bedaquiline exposure." Clin Infect Dis.


Marais, B. J., F. Amanullah, A. Gupta, M. C. Becerra, K. Snow, E. Ngadaya, M. Sharma, A. C. Hesseling, M. Chakaya and A. Zumla (2020). "Tuberculosis in children, adolescents, and women." Lancet Respir Med 8(4): 335-337.


Marais, B. J., J. Chakaya, S. Swaminathan, G. J. Fox, N. Z. Ehtesham, F. Ntoumi, L. Zijenah, M. Maurer and A. Zumla (2020). "Tackling long-term morbidity and mortality after successful tuberculosis treatment." Lancet Infect Dis 20(6): 641-642.


Marais, B. J., M. Nicol and H. J. Zar (2020). "Key advances and remaining challenges in childhood and adolescent tuberculosis." Paediatr Respir Rev.


Marks, G. B., N. V. Nguyen and G. J. Fox (2020). "Community-wide Screening for Tuberculosis. Reply." N Engl J Med 382(12): 1186.


Martinez, L., O. Cords, C. R. Horsburgh, J. R. Andrews, C. Acuna-Villaorduna, S. Desai Ahuja, N. Altet, O. Augusto, D. Baliashvili, S. Basu, M. Becerra, M. Bonnet, W. Henry Boom, M. Borgdorff, F. Boulahbal, A. C. C. Carvalho, J. A. Cayla, T. Chakhaia, P.-C. Chan, T. Cohen, J. Croda, S. Datta, H. Del Corral, J. T. Denholm, R. Dietze, C. C. Dobler, S. Donkor, U. Egere, J. J. Ellner, M. Espinal, C. A. Evans, C.-T. Fang, K. Fielding, G. J. Fox, L. F. García, A. L. García-Basteiro, S. Geis, S. M. Graham, L. Grandjean, D. Hannoun, M. Hatherill, A. M. Hauri, A. C. Hesseling, P. C. Hill, L.-M. Huang, H. Huerga, R. Hussain, L. Jarlsberg, E. C. Jones-López, S. Kato, M. Kato-Maeda, B. Kampmann, H. L. Kirchner, A. Kritski, C. Lange, C.-H. Lee, L.-N. Lee, M.-R. Lee, A. C. Lemos, C. Lienhardt, D.-L. Ling, Q. Liu, N. C. Lo, R. Long, E. Lopez-Varela, P. Lu, M. Magee, L. L. Malone, A. M. Mandalakas, N. A. Martinson, R. Mazahir, M. B. Murray, E. M. Netto, L. Otero, J. Parsonnet, A. Reingold, H. S. Schaaf, J. A. Seddon, S. Sharma, J. Singh, S. Singh, R. Sloot, G. Sotgiu, C. M. Stein, N. T. Iqbal, R. Triasih, L. Trieu, M. F. S. Van Der Loeff, P. Van Der Stuyft, C. Van Schalkwyk, R. Vashishtha, L. M. Verhagen, J. A. Villalba, J.-Y. Wang, C. C. Whalen, T. Yoshiyama, H. J. Zar, J.-P. Zellweger and L. Zhu (2020). "The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis." The Lancet 395(10228): 973-984.


Mason, P. H., C. Lyttleton, G. B. Marks and G. J. Fox (2020). "The technological imperative in tuberculosis care and prevention in Vietnam." Glob Public Health 15(2): 307-320.


Melsew, Y. A., A. I. Adekunle, A. C. Cheng, E. S. McBryde, R. Ragonnet and J. M. Trauer (2020). "Heterogeneous infectiousness in mathematical models of tuberculosis: A systematic review." Epidemics 30: 100374.


Migliori, G. B., S. Tiberi, A. Zumla, E. Petersen, J. M. Chakaya, C. Wejse, M. Muñoz Torrico, R. Duarte, J. W. Alffenaar, H. S. Schaaf, B. J. Marais, D. M. Cirillo, R. Alagna, A. Rendon, E. Pontali, A. Piubello, J. Figueroa, G. Ferlazzo, A. García-Basteiro, R. Centis, D. Visca, L. D'Ambrosio and G. Sotgiu (2020). "MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network." Int J Infect Dis 92s: S15-s25.


Ragonnet, R., J. A. Flegg, S. L. Brilleman, E. W. Tiemersma, Y. A. Melsew, E. S. McBryde and J. M. Trauer (2020). "Revisiting the Natural History of Pulmonary Tuberculosis: a Bayesian Estimation of Natural Recovery and Mortality rates." Clin Infect Dis.


Reuter, A., J. A. Seddon, B. J. Marais and J. Furin (2020). "Preventing tuberculosis in children: A global health emergency." Paediatr Respir Rev.


Schwoebel, V., K. G. Koura, M. Adjobimey, S. Gnanou, A. G. Wandji, J. C. Gody, C. Delacourt, A. Detjen, S. M. Graham, E. Masserey, P. Mselatti, A. Roggi and A. Trébucq (2020). "Tuberculosis contact investigation and short-course preventive therapy among young children in Africa." Int J Tuberc Lung Dis 24(4): 452-460.


Snow, K. J., A. T. Cruz, J. A. Seddon, R. A. Ferrand, S. S. Chiang, J. A. Hughes, B. Kampmann, S. M. Graham, P. J. Dodd, R. M. Houben, J. T. Denholm, S. M. Sawyer and K. Kranzer (2020). "Adolescent tuberculosis." Lancet Child Adolesc Health 4(1): 68-79.


Swaminathan, A., P. du Cros, J. Achar, J. Kliescikova, S. Mirgayosieva and B. Pirmahmadzoda (2020). "A case report of a child with probable drug resistant tuberculous pericarditis with a review of challenges involved in diagnosis, treatment and follow up of children with DR-TB pericarditis." BMC Infect Dis 20(1): 298.


Yeong, C., A. L. Byrne, J. G. Cho, V. Sintchenko, T. Crighton and B. J. Marais (2020). "Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation." Int J Infect Dis 92: 175-180.


Zumla, A., G. Ippolito, F. Ntoumi, V. Seyfert-Margolies, T. J. Nagu, D. Cirillo, J. M. Chakaya, B. Marais and M. Maeurer (2020). "Host-directed therapies and holistic care for tuberculosis." Lancet Respir Med 8(4): 337-340.


Zumla, A., D. Yeboah-Manu, A. L. Michel, E. I. Azhar, J. B. Torrelles, S. I. Cadmus, S. L. Kendall, J. M. Chakaya, B. Marais and R. Kock (2020). "Zoonotic tuberculosis-a call for an open One Health debate." Lancet Infect Dis 20(6): 642-644.

bottom of page